03/13/2026
🌍 Africa Moves Closer to an HIV Vaccine!
South Africa has launched the BRILLIANT 011 first-in-human HIV vaccine trial in Cape Town, enrolling its first participant. This African-led study tests innovative vaccine components targeting HIV strains in Southern Africa and is predominantly led by African women scientists.
✨ A milestone in hope, collaboration, and scientific resilience.
✨ Strengthening immunology expertise across the continent.
Ending HIV requires innovation - and Africa is leading the way.
South African Medical Research Council (2025) - https://rb.gy/l9c415